Bayer Restructures Global Oncology Research Division Amid Cost Pressures and US Litigation
Bayer has announced a consolidation of its global cancer research operations, including reductions in senior research roles. The company says the restructuring is aimed at lowering costs, offsetting legal pressures in the United States, and restoring investor confidence.